Unresearched GLP-1 Agonist Practices
Jul 10, 2024•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
As I discuss the issues of GLP-1 agonist and GLP-1/GIP co-agonist weight loss drugs Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)I’ve been increasingly hearing from people who are engaged in practices with these drugs that are not remotely evidence based.
Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
For the best experience, listen in Metacast app for iOS or Android